Biotechnology

Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis

ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared with 34% receiving placebo, at Week 72. * Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly injectable semaglutide 2...

2026-09-23 10:05 110

Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine

SINGAPORE, Sept. 23, 2026 /PRNewswire/ -- Mayo Clinic Laboratories  and Pathology Asia Holdings  (PAH) have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precisio...

2026-09-23 09:30 73

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

* New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise * Regional hub will support researchers and organizations across the DACH and broader EMEA regions * Center strengthens collaboration, training and innovation within Europe's life...

2026-09-22 21:00 600

Angel Yeast Explores a New Approach to Salt Reduction Without Compromising Flavor

BEIJING, Sept. 22, 2026 /PRNewswire/ -- At the 2026 Food Science Salt Reduction Technology Symposium held recently in Beijing,Angel Yeast (SSE: 600298) joined more than 200 experts and representatives from academia and industry to discuss salt-reduction technologies, ...

2026-09-22 20:54 474

Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders

Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited

2026-09-22 19:30 662

Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session

CHENGDU, China, Sept. 22, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Multiple Phase III clinical studies of the TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) developed...

2026-09-22 15:48 832

Clean Bio Korea to Showcase Indonesia-Validated Air-Fit at Hospital Expo 2026

SEOUL, South Korea, Sept. 21, 2026 /PRNewswire/ -- Clean Bio Co., Ltd, a Korean indoor air quality solutions company, will showcase Air-Fit, its air purification, sterilization and deodorization solution, at Indonesia Int'l Hospital Expo 2026, taking place October 7–10, 2026.

2026-09-21 11:00 1332

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

* Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive therap...

2026-09-21 09:59 1477

Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022

SHANGHAI and HONG KONG, Sept. 21, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...

2026-09-21 08:30 1103

S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University

SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an invitation-only symposium connecting top academic resea...

2026-09-20 20:24 2374

BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem

SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global: On September 17, the BioShanghai Week 2026 opened at Zhangjiang Science Hall in Shanghai. Themed "AI for Biopharma, Health ...

2026-09-20 13:11 1799

Fosun Health Hosts First International Oncology Treatment Forum in Foshan; International Oncology Alliance Officially Established

FOSHAN, China, Sept. 20, 2026 /PRNewswire/ -- The first International Oncology Treatment Forum, hosted by Fosun Health, was held in Foshan, Guangdong Province, China. Oncology experts from multiple countries and regions participated in the exchanges, discussing the development of international r...

2026-09-20 09:00 1983

Jiahui Health Highlights China's Growing Role in Global Medical Tourism at WTO Public Forum 2026

GENEVA, Sept. 18, 2026 /PRNewswire/ -- China is seeing growing momentum in inbound medical tourism, driven by expanding access to innovative therapies, visa facilitation and the development of internationally oriented healthcare services, Dr. John K. Hsiang, Chairman of Jiahui Health Executive Co...

2026-09-18 21:00 1786

2026 Tang Prize Award Ceremony Honors Six Laureates

Outstanding Achievements for Global Well-Being and Our Shared Future TAIPEI, Sept. 18, 2026 /PRNewswire/ -- The 2026 Tang Prize Award Ceremony brought together all six laureates in Taipei on September 18, with five receiving their awards in person and Biopharmaceutical Science laureate Dr. Steve...

2026-09-18 19:56 543

A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%

PARIS, Sept. 18, 2026 /PRNewswire/ --  Virbac Headquarters, Carros, France * H1 2026 delivered a robust revenue growth of +7.4% and an adjusted EBIT margin of 18.8% at CERS: ○  Revenue growth is coming from both segm...

2026-09-18 00:33 2169

New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline

ALCOR Scientific's iSED® analyzers reshape lab logistics and improve patient care for one of medicine's most widely used tests * Seven times longer stability, independently validated. ESR samples on ALCOR Scientific's iSED analyzer remained accurate for up to 28 hours at room temperature and 4...

2026-09-17 21:00 1762

Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advances LONDON, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc ...

2026-09-17 15:05 1535

OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody

* Cesalatamig is Currently Being Evaluated in Phase 1/2 Studies in the United States (NCT06635785 ) and in China (CTR20253261

2026-09-16 19:00 2055

GHIT Fund Launches "NTDpedia" to Help Turn Apathy Into Action Against Neglected Tropical Diseases

The interactive educational website makes NTDs understandable to a general audience, the first step toward public support that drives R&D for the 1.5 billion people affected by these diseases TOKYO, Sept. 16, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced the ...

2026-09-16 13:00 1551

Ferronova announces preliminary results of MAGMAP, a 62-patient gastric and oesophageal cancer trial investigating lymph node mapping

KYOTO, Japan, Sept. 16, 2026 /PRNewswire/ -- Australian medical technology company Ferronova has announced preliminary findings from the MAGMAP multi-centre trial involving 62 gastric and oesophageal patients evaluating the safety and feasibility of a new nanoparticle-based platform to assist cl...

2026-09-16 12:00 2333
12345 ... 185